Showing results (1941-1950 of 2,107) with videos related to
Sort By:
Pageof 211
Nanomedicine : Nanotechnology, Biology, and Medicine|March 13, 2019
Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancerHanna K Sanoff, Dominic H Moon, Dominic T Moore, et al.Autism : the International Journal of Research and Practice|March 30, 2018
Computer vision analysis captures atypical attention in toddlers with autismKathleen Campbell, Kimberly Lh Carpenter, Jordan Hashemi, et al.Cancer|March 27, 2018
High frequency of the PNPLA3 rs738409 [G] single-nucleotide polymorphism in Hmong individuals as a potential basis for a predisposition to chronic liver diseaseClifford G Tepper, Julie H T Dang, Susan L Stewart, et al.Obstetrics and Gynecology Clinics of North America|May 6, 2023
Safety and Effectiveness of Maternal COVID-19 Vaccines Among Pregnant People and InfantsKatherine E Fleming-Dutra, Lauren Head Zauche, Lauren E Roper, et al.Oncogene|July 27, 2007
Inappropriate activation of androgen receptor by relaxin via beta-catenin pathwayS Liu, R L Vinall, C Tepper, et al.International Journal of Radiation Oncology, Biology, Physics|November 20, 2015
Phase 2 Trial of De-intensified Chemoradiation Therapy for Favorable-Risk Human Papillomavirus-Associated Oropharyngeal Squamous Cell CarcinomaBhishamjit S Chera, Robert J Amdur, Joel Tepper, et al.International Journal of Radiation Oncology, Biology, Physics|July 16, 2010
Nuclear factor κ-light chain-enhancer of activated B cells is activated by radiotherapy and is prognostic for overall survival in patients with rectal cancer treated with preoperative fluorouracil-based chemoradiotheraphyBert H O'Neil, William K Funkhouser, Benjamin F Calvo, et al.Mabs|July 23, 2026
Conditional activation of IL-12 through a Fibronectin-EDB dependent switch gateJosephine D Kahn, Kothai Parthiban, Peter Slavny, et al.International Journal of Clinical Practice|August 16, 2003
Establishing principles for migraine management in primary careA J Dowson, J Sender, S Lipscombe, et al.Plos One|August 14, 2015
Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted TherapyChong-Xian Pan, Hongyong Zhang, Clifford G Tepper, et al.Pageof 211